Risk factors for oral hairy leukoplakia in HIV-infected adults of Brazil

Journal of Oral Pathology and Medicine

Volumn 35, Issue 6, 2006, Pages 321-326

  Moura, Mariela Dutra Gontijo ^a,b   Grossmann, Soraya De Mattos Camargo ^a   Fonseca, Linaena Méricy Da Silva ^a,b   Senna, Maria Inês Barreiros ^a,b   Mesquita, Ricardo Alves ^a,b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Belo Horizonte City Health Department   (Brazil)

Author keywords

HAART; HIV infection; Oral hairy leukoplakia; Risk factors

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; FLUCONAZOLE;

ADULT; ARTICLE; BRAZIL; CHI SQUARE TEST; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOLOGY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FISHER EXACT TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; STATISTICAL ANALYSIS; THRUSH; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; CD4 LYMPHOCYTE COUNT; CHI-SQUARE DISTRIBUTION; FEMALE; HIV INFECTIONS; HUMANS; LEUKOPLAKIA, HAIRY; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS; VIRAL LOAD;

EID: 33745012570     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2006.00428.x     Document Type: Article

References (46)

1. Birnbaum W Hodgson TA Reichart PA Sherson W Nittayananta SW Axell TE. Prognostic significance of HIV-associated oral lesions and their relation to therapy. Oral Dis 2002 8 Suppl. 2 110 14.
2. Patel A Glick M. Oral manifestations associated with HIV infection: evaluation, assessment, and significance. Gen Dent 2003 51 : 153 6.
3. Ravina A Ficarra G Chiodo M Mazzetti M Romagnani S. Relationship of circulating CD4+ T-lymphocytes and p24 antigenemia to the risk of developing AIDS in HIV-infected subjects with oral hairy leukoplakia. J Oral Pathol Med 1996 25 : 108 11.
4. Ramirez-Amador V Esquivel-Pedraza L Ponce De León S Ponce De León S. Prognostic value of oral candidiasis and hairy leukoplakia in 111 Mexican HIV-infected patients. J Oral Pathol Med 1996 25 : 206 11.
5. Husak R Garbe C Orfanos CE. Oral hairy leukoplakia in 71 HIV-seropositive patients: clinical symptoms, relation to immunologic status, and prognostic significance. J Am Acad Dermatol 1996 35 : 928 34.
6. Begg MD Lamster IB Panageas KS Mitchell-Lewis D Phelan JA Grbic JT. A prospective study of oral lesions and their predictive value for progression of HIV disease. Oral Dis 1997 3 : 176 83.
7. Margiotta V Campisi G Mancuso S Accurso V Abbadessa V. HIV infection: oral lesions, CD4+ cell count and viral load in an Italian study population. J Oral Pathol Med 1999 28 : 173 7.
8. Patton LL Mckaig R Strauss R Rogers D Eron JJ Jr.. Changing prevalence of oral manifestation of human immunodeficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 89 : 299 304.
9. Schmidt-Westhausen AM Priepke F Bergmann FJ Reichart PA. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med 2000 29 : 336 41.
10. Chattopadhyay A Caplan DJ Slade GD Shugars DC Tien H Patton LL. Incidence of oral candidiasis and oral hairy leukoplakia in HIV-infected adults in North Carolina. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005 99 : 39 47.
11. Chattopadhyay A Caplan DJ Slade GD Shugars DC Tien HC Patton LL. Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults. Community Dent Oral Epidemiol 2005 33 : 35 44.
12. Pinheiro A Marcenes W Zakrzewska JM Robinson PG. Dental and oral lesions in HIV infected patients: a study in Brazil. Int Dent J 2004 54 : 131 7.
13. World Health Organization. Oral health survey: basic methods, 4 edn. Who Health Organization, Geneva, 1997.
14. Tappuni AR Fleming GJP. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001 92 : 623 8.
15. Kerdpon D Pongsiriwet S Pangsomboon K, et al. Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in northern and southern Thai patients. Oral Dis 2004 10 : 138 44.
16. Patton LL. Hematologic abnormalities among HIV-infected patients: associations of significance for dentistry. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999 88 : 561 7.
17. Tarzia O. Importância do fluxo salivar com relação à saúde bucal. CECADE News 1993 1 : 13 17.
18. EC-clearinghouse on oral problems related to HIV infection and WHO collaborating centre on oral manifestations of immunodeficiency virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993 22 : 289 91.
19. Kratochvil FJ Riordan P Auclair PL Huber MA Kragel PJ. Diagnosis of oral hairy leukoplakia by ultrastructural examination of exfoliative cytologic specimens. Oral Surg Oral Med Oral Pathol 1990 70 : 613 8.
20. Fraga-Fernandes J Vicandi-Plaza B. Diagnosis of hairy leukoplakia by exfoliative cytologic methods. Am J Clin Pathol 1992 97 : 262 6.
21. Migliorati CA Jones AC Baughman PA. Use of exfoliative cytology in the diagnosis of oral hairy leukoplakia. Oral Surg Oral Med Oral Pathol 1993 76 : 704 10.
22. Epstein JB Fatahzadeh M Matisic J Anderson G. Exfoliative cytology and electron microscopy in the diagnosis of hairy leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995 79 : 564 9.
23. Logan RM Coates EA Pierce AM Wilson DF. A retrospective analysis of oral hairy leukoplakia in South Australia. Aust Dent J 2001 46 : 108 13.
24. Eyeson JD Tenant-Flowers M Cooper DJ Johnson NW Warnakulasuriya KA. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London. J Oral Pathol Med 2002 31 : 169 74.
25. Bendick C Scheifele C Reichart PA. Oral manifestations in 101 Cambodians with HIV and AIDS. J Oral Pathol Med 2002 31 : 1 4.
26. Ramirez-Amador V Esquivel-Pedraza L Sierra-Madero J Anaya-Saavedra G Gonzalez-Ramirez I Ponce-DE-Leon S. The changing clinical spectrum of human immunodeficiency virus (HIV)-related oral lesions in 1,000 consecutive patients: a 12-year study in a referral center in Mexico. Medicine (Baltimore) 2003 82 : 39 50.
27. Bravo IM Correnti M Escalona L, et al. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population. Med Oral Patol Oral Cir Bucal 2006 11 : E33 9.
28. Patton LL Phelan JA Ramos-Gomez FJ Nittayananta W Shiboski CH Mbuguye TL. Prevalence and classification of HIV-associated oral lesions. Oral Dis 2002 8 : 98 109.
29. Brehmer-Andersson E Lucht E Lindskog S Ekman M Biberfeld P. Oral hairy leukoplakia: pathogenetic aspects and significance of the lesion. Acta Dermatol Venereol 1994 74 : 81 89.
30. Patton LL Mckaig RG Strauss RP Eron JJ Jr.. Oral manifestations of HIV in a southeast USA population. Oral Dis 1998 4 : 164 9.
31. Barr CE Lopez MR Rua-Dobles A Miller LK Mathur-Wagh U Turgeon LR. HIV-associated oral lesions: immunologic, virologic and salivary parameters. J Oral Pathol Med 1992 21 : 295 8.
32. Kolokotronis A Kioses V Antoniades D Mandraveli K Doutsos I Papanayotou P. Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia. Oral Surg Oral Med Oral Pathol 1994 78 : 41 46.
33. Greenspan D Komaroff E Redford M, et al. Oral mucosal lesions and HIV viral load in the women's interagency HIV study (WIHS). J Acquir Immune Defic Syndr 2000 25 : 44 50.
34. Patton LL. Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 90 : 182 8.
35. Shiboski CH Hilton JF Neuhaus JM Canchola A Greenspan D. Human immunodeficiency virus-related oral manifestations and gender: a longitudinal analysis. Arch Intern Med 1996 156 : 2249 54.
36. Brasil. Ministério da. Boletim epidemiológico aids Saúde, Secretaria de Vigilância em Saúde, Programa nacional de DST e Aids. Ano XVII, no 1. Ministério da Saúde, Brasília (Brasil), 2004.
37. Secretaria De Estado De Saúde De Minas Gerais. Dados de AIDS em Minas Gerais de 2004 (database on the Internet). Coordenadoria estadual de DST/aids, Belo Horizonte (MG), 2004. (Available from: http://www.saude.mg.gov. br:8180/saude/viewController.jsp?page=63 updated 2005 January 27; cited 2005 April 11.
38. Bureau A Shiboski S Hughes JP. Applications of continuous time hidden Markov models to the study of misclassified disease outcomes. Stat Med 2003 22 : 441 62.
39. Greenspan D Shirlaw PJ. Management of the oral mucosal lesions seen in association with HIV infection. Oral Dis 1997 3 Suppl. 1 229 34.
40. Boulter AW Soltanpoor N Swan AV Birnbaum W Johnson NW Teo CG. Risk factors associated with Epstein-Barr virus replication in oral epithelial cells of HIV-infected individuals. AIDS 1996 10 : 935 40.
41. Katz MH Greenspan D Heinic GS, et al. Resolution of hairy leukoplakia: an observational trial of zidovudine versus no treatment. J Infect Dis 1991 164 : 1240 1 (letter).
42. Nittayananta W Chanowanna N Sripatanakul S Winn T. Risk factors associated with oral lesions in HIV-infected heterosexual people and intravenous drug users in Thailand. J Oral Pathol Med 2001 30 : 224 30.
43. Conley LJ Bush TJ Buchbinder SP Penley KA Judson FN Holmberg SD. The association between cigarette smoking and selected HIV-related medical conditions. AIDS 1996 10 : 1121 6.
44. Shiboski CH Neuhaus JM Greenspan D Greenspan JS. Effect of receptive oral sex and smoking on the incidence of hairy leukoplakia in HIV-positive gay men. J Acquir Immune Defic Syndr 1999 21 : 236 42.
45. Ramirez-Amador V Esquivel-Pedraza L Sierra-Madero J Ponce-De-Leon S Ponce-De-Leon S. Oral manifestations of HIV infection by gender and transmission category in Mexico City. J Oral Pathol Med 1998 27 : 135 40.
46. Shiboski CH Hilton JF Neuhaus JM Canchola A Greenspan D. Human immunodeficiency virus-related oral manifestations and gender: a longitudinal analysis. Arch Intern Med 1996 156 : 2249 54.